Tennessee_ATO
Footballguy
Pfizer reported net profits north of the entire vaccine sector's revenues in 2013. My point is only that vaccinations make some profits for sure, but even though the numbers are big they're not big when compared to those behemoths.I agree.The top 5 vaccine manufactures in your link (90% of the market) are: Sanofi, Merck, GSK, Pfizer, and Novartis. Those aren't "vaccine companies" those are "pharmaceutical companies with a vaccine division".2012 vaccine industry was about $25BFrom what I've read up on it today, there are basically only 5 vaccine companies worldwide. It is a very different animal from the other parts of the pharmaceutical industry.But a little scale is needed. Humira grossed more than $9B in 1 year. That's 1 drug, 1 R&D cost, 1 manufacturing facility. Lipitor annihilated those numbers. So, ~$4B for an entires sector sounds big, but whatever profit is netted is likely a rounding error for the backbone of what those companies do.http://www.forbes.com/sites/simonking/2013/01/28/the-best-selling-drugs-of-all-time-humira-joins-the-elite/To do some further math on the GROSS revenue provided by infant vaccines:
Say a 90% participation rate accross the population for a single dose, it generates (4,000,000 x .9 x $50) = $180MM per year
Per the CDC, there are 22 recommended vaccines in the first year. Using $180MM per dose, that yields $3.96 billion per year of revenue generated in year 1 of a child's life. A $4B industry is nothing to sneeze at.
And that is not even taking into consideration the remaining child vaccines or adult vaccines.
I'm not saying profit isn't being made. It's just not terribly important to the bottom line of those companies.
It also seems that the only real "customers" are the WHO and CDC who regulate what vaccines are approved and what companies are approved to manufacture and distribute them.
Regardless, who develops and sells anything without profit being involved?